Compile Data Set for Download or QSAR
Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 476
TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271332(US10064853, Compound 1)
Affinity DataIC50: 250nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271332(US10064853, Compound 1)
Affinity DataIC50: 250nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271339(US10064853, Compound 14)
Affinity DataIC50: 650nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271339(US10064853, Compound 14)
Affinity DataIC50: 650nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271338(US10064853, Compound 13)
Affinity DataIC50: 850nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271338(US10064853, Compound 13)
Affinity DataIC50: 850nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271337(US10064853, Compound 9)
Affinity DataIC50: 2.25E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271337(US10064853, Compound 9)
Affinity DataIC50: 2.25E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271341(US10064853, Compound 16)
Affinity DataIC50: 3.00E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271341(US10064853, Compound 16)
Affinity DataIC50: 3.00E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271342(US10064853, Compound 17)
Affinity DataIC50: 4.00E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271342(US10064853, Compound 17)
Affinity DataIC50: 4.00E+3nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271344(US10064853, Compound 19)
Affinity DataIC50: 2.25E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271344(US10064853, Compound 19)
Affinity DataIC50: 2.25E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271333(US10064853, Compound 4)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271334(US10064853, Compound 5)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271335(US10064853, Compound 6)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271336(US10064853, Compound 8)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271343(US10064853, Compound 18)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271340(US10064853, Compound 15)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271336(US10064853, Compound 8)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271340(US10064853, Compound 15)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271335(US10064853, Compound 6)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271334(US10064853, Compound 5)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271343(US10064853, Compound 18)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetProtein disulfide-isomerase(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM271333(US10064853, Compound 4)
Affinity DataIC50: 3.00E+4nMAssay Description:Insulin reductase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent